Tags: Drug.
Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It binds to KIR2DL1/2L3.This drug was developed by Innate Pharma and is licenced to Bristol-Myers Squibb.
Loading...
This page contains content from the copyrighted Wikipedia article "Lirilumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.